Speakers

Bertha Coombs is CNBC’s senior health care reporter, covering health care services and policy, as well as financial markets and business news stories throughout the business day. 

Her health care coverage at CNBC has ranged from covering the implementation of the Affordable Care Act, the evolution of health care technology, and the continuing push to disrupt pharmacy models and lower drug costs, to the launch of the IRA Medicare drug price negotiations. 

Over twenty years at CNBC, Coombs has covered the tech sector from the Nasdaq Marketsite and general market news from the floor of the New York Stock Exchange.  Before joining the network, she reported for the pioneering streaming business network, Yahoo Finance Vision. Prior to that, she served as a reporter for ABC News One and a substitute anchor for “World News Now” and “World News This Morning.”  She began her reporting career in local news as a Leo Beranek Fellow at WCVB-TV in Boston. 

Coombs is a graduate of Yale University. Born in Havana, Cuba, she speaks fluent Spanish. 

Michael Dowling is one of the health care industry’s most highly respected voices, achieving the No. 1 ranking in Modern Healthcare magazine’s 2022 list of the “100 Most Influential People in Healthcare.” As a health care executive over the past three decades, he has been a no-excuses advocate for reforms that have helped the industry become more patient-focused and committed to quality and safety. His willingness to take a stand on societal issues such as gun violence and immigration has earned widespread praise and recognition from peers and the news media. During his years in academia and government, Mr. Dowling has distinguished himself as a compassionate voice for those in need, developing and promoting innovative health and human services policies. 

As president and CEO of Northwell Health for 22 years, he has demonstrated invaluable leadership in overseeing a rapidly expanding clinical, research and academic enterprise with annual revenue of $18 billion. With a workforce of more than 85,000, Northwell is the largest health care provider and private employer in New York State, caring for more than two million people annually through a vast network of 21 hospitals, more than 900 outpatient facilities—including 220 primary care practices and 50-plus urgent care centers—along with home care, rehabilitation and end-of-life services. 

Hailing from Ireland, Mr. Dowling bridges borders and brings a global perspective to health care. In 2020, he received the Presidential Distinguished Service Award for the Irish Abroad, which recognized his contributions to Ireland and to Irish communities abroad, presented by the President of Ireland. He also received an honorary fellowship of the Royal College of Physicians of Ireland and is a board member of the Foreign Policy Association. He is a member of the Institute of Medicine of the National Academies of Science, and the North American Board of the Smurfit School of Business at University College in Dublin, Ireland. He also earned his bachelor’s degree from University College Cork, and went on to receive honorary doctorates from Queens University Belfast and University College Dublin. Mr. Dowling was the Grand Marshal of New York City’s St. Patrick’s Day Parade in 2017, when he was also inducted into the Irish America Hall of Fame. 

Mr. Dowling has invested heavily in Northwell’s research arm, the Feinstein Institutes for Medical Research, home to 50 research labs, 3,000 clinical research trials, and 5,000 scientists and staff who are transforming the treatment of conditions like lupus, arthritis, sepsis, cancer, psychiatric illness and Alzheimer’s disease. Feinstein has gained stature as the global headquarters of bioelectronic medicine research, where physician scientists are tapping neural pathways that signal the body to heal itself, reducing reliance on prescription drugs. 

Under Mr. Dowling’s leadership, Northwell has also pursued a visionary approach to medical education, developing innovative curricula at its Zucker School of Medicine and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Northwell’s graduate medical education programs have become one of the nation’s largest, training more than 1,900 medical residents and fellows annually. Further underscoring his commitment to education, Mr. Dowling’s first act when becoming Northwell’s CEO in 2002 was creating a corporate university, the Center for Learning & Innovation, which has helped instill a culture of lifelong learning among employees at all levels of the organization. 

Mr. Dowling’s highly visible leadership style enabled the health system to successfully navigate the intense challenges of the COVID-19 pandemic, most notably in 2020 when the New York metropolitan area was at the epicenter of the epidemic’s first wave. Mr. Dowling detailed his and Northwell’s experiences in a book titled Leading Through a Pandemic: The Inside Story of Humanity, Innovation, and Lessons Learned During the COVID-19 Crisis. 

Northwell clinicians treated more than 350,000 COVID patients and the health system used its innovative culture to significantly expand bed capacity and leverage its resources to ensure adequate supplies of lifesaving drugs, ventilators, personal protective equipment and other essential provisions to protect patients and caregivers, including administering the nation’s first COVID vaccines in December 2020. 

In addition to his 2020 book about Northwell’s response to the COVID-19 pandemic, Mr. Dowling is the co-author of a 2020 memoir titled After the Roof Caved In: An Immigrant’s Journey from Ireland to America, which chronicles his poverty-stricken childhood in Ireland, his years as a social policy expert in academia and in New York State government, and his ascent to becoming one of the health care industry’s preeminent leaders. He is also the co-author of the 2018 book, Health Care Reboot: Megatrends Energizing American Medicine, about the trends that are driving the nation’s health care system toward greater quality, safety, access and affordability. 

Prior to becoming CEO, Mr. Dowling was the health system’s executive vice president and chief operating officer, playing a key role in initiating mergers and acquisitions that enabled Northwell to become New York’s largest integrated health system. Before joining Northwell in 1995, he was a senior vice president at Empire Blue Cross/Blue Shield. Mr. Dowling served in New York State government for 12 years during the 1980s and early 1990s, including seven years as deputy secretary of human services to former New York Governor Mario Cuomo, state director of health, education and human services, and later, commissioner of the New York State Department of Social Services. He initiated numerous innovative programs aimed at expanding primary care access to the medically underserved and uninsured, and helping the state to combat the crack cocaine epidemic at that time. 

Before his public service career, Mr. Dowling was a professor of social policy and assistant dean at the Fordham University Graduate School of Social Services, and director of the Fordham campus in Westchester County. He was also a former instructor at the Harvard School of Public Health Center for Continuing Professional Education. 

Mr. Dowling has been honored with many awards and recognitions throughout his career, including: The Conference Board’s 2023 Committee for Economic Development Distinguished Leadership Award, the 2021 Glassdoor Employees’ Choice Award, the Columbia University School of Business’ 2020 Deming Cup for Operational Excellence, the 2012 B’nai B’rith National Healthcare Award, the National Center for Healthcare Leadership’s 2011 Gail L. Warden Leadership Excellence Award, the Healthcare Information and Management Systems’ 2011 CEO IT Achievement Award, the Ellis Island Honors Society’s 2007 Medal of Honor, the Foreign Policy Association Medal, the American Jewish Committee’s National Human Relations Award, the State University of New York’s Nelson A. Rockefeller College of Public Affairs and Policy’s Distinguished Public Service Award, the Mental Health Association of New York State’s Outstanding Public Service Award, and the American Society for Public Administration’s Alfred E. Smith Award. 

Mr. Dowling is a member of the National Center for Healthcare Leadership, the Greater New York Hospital Association, the Healthcare Association of New York State (HANYS), the League of Voluntary Hospitals of New York, the Institute for Healthcare Improvement (IHI), The Healthcare Institute and the Long Island Association and many other professional organizations. 

Dr. Geoffrey Ling is a pharmacologist and physician and co-founder of On Demand Pharmaceuticals. Clinically, he is a professor of neurology, neurosurgery and anesthesiology and critical care medicine at Johns Hopkins University and the Uniformed Services University of the Health Sciences, and an attending neuro critical care physician at Johns Hopkins Hospital. He serves as the Chair of the Veterans Administration’s National Research Advisory Council.

Dr. Ling is a retired U.S. Army colonel after 21 years on active duty. He served as an intensive care physician with the 452nd CSH (combat support hospital) in OEF-Afghanistan (2003) and 86th CSH and 10th CSH in OIF-Iraq (2005). Also, COL Ling has had four in-theater missions as a member of the Joint Chiefs of Staff “Gray Team” to assess traumatic brain injury (TBI) care in both combat theaters (2009, 2011). The 10th CSH named him their first “Physician of the Month.” Dr. Ling was also a “requested by name” consultant to Congresswoman Gabby Gifford’s trauma team following her tragic attack.

He was the Founding Director of the Biological Technologies Office at the Defense Advanced Research Projects Agency (DARPA), where he was previously a program manager and Deputy Director of the Defense Sciences Office. He served as an Assistant Director in the Science Division of President Obama’s White House Office of Science, Technology and Policy (OSTP). His BA with honors is from Washington University in St. Louis, MD from Georgetown University (elected to AOA) and his PhD in neuropharmacology is from Cornell University. He completed his neurology residency at Walter Reed Army Medical Center, neuro critical care fellowship at Johns Hopkins and research fellowship in neuropharmacology at the Memorial Sloan Kettering Cancer Center. He is board certified in both neurology and neuro critical care. He has published more than 200 peer-reviewed articles and book chapters.

Kevin J. Tracey, is President and CEO and the Karches Family Distinguished Chair in Medical Research at The Feinstein Institutes for Medical Research; Professor of Neurosurgery and Molecular Medicine at the Zucker School of Medicine at Hofstra-Northwell; and Executive Vice President, Research, at Northwell Health, in New York. A leader in the scientific fields of inflammation and bioelectronic medicine, his contributions include discovery and molecular mapping neural circuits controlling immunity and identifying the therapeutic action of monoclonal anti-TNF antibodies.

Professor Tracey received his B.S. (Chemistry, summa cum laude, Phi Beta Kappa) from Boston College in 1979, and his M.D. from Boston University in 1983.  He trained in neurosurgery from 1983 to 1992 at the New York Hospital-Cornell University Medical Center and was a guest investigator at the Rockefeller University before moving in 1992 to The Feinstein Institutes.

An inventor with more than 75 United States patents, author of more than 400 scientific publications, he cofounded the Global Sepsis Alliance, a non-profit organization supporting the efforts of >1 million sepsis caregivers in more than 70 countries. His honors and awards include a Doctorates honoris causa from the Karolinska Institute, Stockholm, Sweden, the University of Fribourg, Switzerland and Hofstra University, New York; the Boston University Distinguished Alumni Award; Fellow of the AIMBE Class (2020), the Harvey Society lecture, New York; and lectureships from Harvard, Yale, Rockefeller University, the NIH, and elsewhere. His memberships include the American Society of Clinical Investigation (2001), the American Association of Physicians (2009), the Long Island Technology Hall of Fame (2012), Alpha Omega Alpha (2014), the American Association for the Advancement of Science (2014), and the American Institute for Medical and Biological Engineering (2020). Professor Tracey is author of Fatal Sequence (Dana Press), and delivers lectures nationally and internationally on inflammation, sepsis, the neuroscience of immunity, and bioelectronic medicine.

David Battinelli, MD, is Northwell Health’s physician-in-chief on all clinical, research and education issues. This role follows a transition from his position as Northwell’s senior vice president and chief medical officer (CMO), in which he was responsible for the overall professional management of clinical, education, research and operational issues related to medical and clinical affairs.

Dr. Battinelli is also dean and Betsey Whitney Cushing Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. A founding member of the Zucker School of Medicine, he previously served as the vice dean and earlier as the dean for medical education and chaired the committee charged with developing the new medical school’s curriculum.

While CMO, he also served as the chief operating officer for the Feinstein Institutes for Medical Research where he oversaw all operational and budgetary issues for Northwell’s research enterprise growing extramural funding and endowments while improving overall efficiency and research productivity.

Previously, he served as the health system’s chief academic officer and senior vice president of academic affairs, in charge of all undergraduate and graduate educational programs, continuing medical education, and academic affairs and institutional relationships.

A board-certified internist, Dr. Battinelli came to Northwell Health from Boston Medical Center (BMC), where he served as vice chair for education, program director for the internal medicine residency program, and professor of medicine at Boston University School of Medicine. He was also an active staff physician at BMC and the Boston Veterans Administration.

Dr. Battinelli is a past president of the Association of Program Directors in Internal Medicine. He has worked closely with and served on numerous committees for a variety of national medical organizations including the Alliance for Academic Internal Medicine, American Board of Internal Medicine, American College of Physicians and the Accreditation Committee on Graduate Medical Education. In addition, he has lectured extensively on clinical education, faculty development of teaching skills and internal medicine, and is a noted speaker and author on these subjects.

Dr. Battinelli earned his medical degree from the Rutgers School of Biomedical and Health Sciences and a Bachelor of Science degree from the University of Scranton. He completed his residency and chief residency at Boston City Hospital.

Tyler Mathisen co-anchors CNBC’s “Power Lunch,” one of the network’s longest running program franchises. He is also Vice President, Events Strategy for CNBC, working closely with the network’s events team to grow the rapidly expanding business.

Previously, Mathisen was co-anchor of “Nightly Business Report,” an award-winning evening business news program produced by CNBC for U.S. public television. In 2014, NBR was named best radio/TV show by the Society of American Business Editors and Writers (SABEW). Since joining CNBC in 1997, Mathisen has held a number of positions including managing editor of CNBC Business News, responsible for directing the network’s daily content and coverage. He was also co-anchor of CNBC’s “Closing Bell.”

Mathisen has reported one-hour documentaries for the network including “Best Buy: The Big Box Fights Back,” “Supermarkets Inc: Inside a $500 Billion Money Machine” and “Death: It’s a Living.” Mathisen was also host of the CNBC series “How I Made My Millions.”

Prior to CNBC, Mathisen spent 15 years as a writer, senior editor and top editor for Money magazine. Among other duties, he supervised the magazine’s mutual funds coverage, its annual investment forecast issue and its expansion into electronic journalism, for which it won the first-ever National Magazine Award for New Media in 1997.

In 1993, Mathisen won the American University-Investment Company Institute Award for Personal Finance Journalism for a televised series on “Caring for Aging Parents,” which aired on ABC’s “Good Morning America.” Mathisen served as money editor of “GMA” from 1991 to 1997. He also won an Emmy Award for a report on the 1987 stock market crash that aired on New York’s WCBS-TV.

A native of Arlington,Va., Mathisen graduated with distinction from the University of Virginia.

Cori Bargmann is a neuroscientist and geneticist. She received a BS in biochemistry from the University of Georgia and a Ph.D. from the Massachusetts Institute of Technology, where she studied the neu/HER2 oncogene with Robert A. Weinberg. Her work on the neurobiology and genetics of behavior began during a postdoctoral fellowship with H. Robert Horvitz at MIT. She has studied the relationships between genes, circuits, and behaviors in the genetically tractable nematode worm Caenorhabditis elegans as a faculty member at the University of California, San Francisco (1991-2004) and at the Rockefeller University as the Torsten N. Wiesel Professor and Head of the Lulu and Anthony Wang Laboratory of Neural Circuits and Behavior (2004-present). She was an HHMI Investigator from 1995-2016. Highlights of her lab’s work include identifying the first direct link between an olfactory receptor protein and an animal’s odor recognition, demonstrating that a pre-patterned map of olfactory and taste preference converts sensory perception into stereotyped behaviors, elucidating the circuit logic connecting odors to fixed and variable behavioral responses, mapping natural trait variation in social and foraging behaviors to receptors for neuromodulators, and discovering many molecules involved in nervous system wiring, including a “matchmaker” for synaptic specificity. This work has been recognized by scientific honors including a 2012 Kavli Prize in Neuroscience and the 2013 Breakthrough Prize in Life Sciences. In 2013-2014, she co-chaired the NIH working group to the Advisory Committee to the NIH Director for President Obama’s Brain Initiative. In 2016 she joined the Chan Zuckerberg Initiative as its first Head of Science. Chan Zuckerberg Science has the goal of advancing basic science and technology that will make it possible to cure, prevent, or manage all diseases by the end of the century. To accelerate the pace of biomedical science, the Chan Zuckerberg Initiative supports collaborations between experimental and computational scientists and engineers, technologies to advance scientific discovery, and open science.

Since 1989, Stanley M. Bergman has been Chairman of the Board and CEO of Henry Schein, Inc., a Fortune 500® company and the world’s largest provider of health care products and services to office-based dental and medical practitioners, with more than 19,000 Team Schein Members and operations or affiliates in 31 countries. Henry Schein is a member of the S&P 500® index. In 2019, the Company’s sales from continuing operations reached $10.0 billion. Henry Schein has been a Fortune World’s Most Admired Company for 19 consecutive years.

Mr. Bergman serves as a board member or advisor for numerous institutions including New York University College of Dentistry; the University of Pennsylvania School of Dental Medicine; the Columbia University Medical Center; University of the People; Hebrew University; Tel Aviv University; the University of the Witwatersrand Fund; The World Economic Forum’s Health Care Governors; the Business Council for International Understanding, the Japan Society and the Metropolitan Opera. Mr. Bergman is an honorary member of the American Dental Association and the Alpha Omega Dental Fraternity. Mr. Bergman is the recipient of the Ellis Island Medal of Honor; the CR Magazine Corporate Responsibility Lifetime Achievement Award; the 2017 CEO of the Year award by Chief Executive Magazine; Honorary Doctorates from The University of the Witwatersrand, Western University of Health Sciences, Hofstra University, A.T. Still University’s Arizona School of Dentistry and Oral Health, Case Western Reserve University and Farmingdale State College (SUNY); and Honorary Fellowship from King’s College London – Dental Institute and the International College of Dentists.

Andrew M. Cuomo is the 56th Governor of New York, having assumed office on January 1, 2011. Throughout his entire life, Andrew Cuomo has had the same values and the same principles; he has not only believed in those values and principles, but he has developed the skills to fight for them – and to win.

As Governor, Andrew Cuomo has fought for social, racial and economic justice for all New Yorkers.
Under his leadership, New York passed marriage equality, a $15 minimum wage, the strongest paid family leave program in the nation, the strongest gun safety laws in the nation, equal rights for women, greater protections for immigrants, the largest investment in education in state history, cut taxes for the middle class, implemented a 2 percent property tax cap, put more New Yorkers to work than ever before, and became the first state in the nation to offer free college tuition for middle-class families. He also got the state building again – taking on projects that had been stalled for decades and using union labor every step of the way.

Born on December 6, 1957, Andrew M. Cuomo was the second child of Mario Cuomo & Matilda Raffa Cuomo. His paternal grandparents Andrea and Immaculato Cuomo emigrated from Salerno, Italy to South Jamaica, Queens in the 1920s, where Andrea ran a small grocery store.
In Queens, Andrew Cuomo learned the reality of the middle-class, working family struggle. He graduated from Fordham University in the Bronx in 1979 and received his law degree from Albany Law School in 1982. After law school, Andrew Cuomo headed the Transition Committee for then Governor-Elect Mario Cuomo and then served as an advisor to the Governor taking a salary of $1 a year. Mario Cuomo instilled in him the belief that government was the vehicle to make change and do justice.

Andrew Cuomo’s fight for justice focused on helping the neediest and addressing one of the most desperate situations of the time – homelessness. At the age of 28 he founded the Housing Enterprise for the Less Privileged (HELP) – a not-for-profit that set a national model for serving the homeless.

After the 1996 election, President Clinton appointed Andrew Cuomo to serve as HUD Secretary. He worked to transform the agency from a wasteful and inefficient bureaucracy to an effective driver of economic development and housing opportunities. In 2006, Andrew Cuomo was elected New York State Attorney General, and his agenda remained unchanged – to fight for justice: social, racial, and economic justice. He fought discrimination in rental apartments, challenged corporate abuse of the middle class, and took on the big banks that were squandering billions of dollars in bail-out money.

In November 2018, Governor Cuomo was re-elected with the largest number of votes of any governor in both the primary and the general elections. In his third term, he continues his fight for justice in the face of a federal government that is threatening the essential American compact of opportunity for all and acceptance of all.

Andrew Cuomo is the proud father of three girls, Mariah, Cara, and Michaela.

Joaquin Duato is a globally experienced, values-driven health care business leader and currently Vice Chairman of the Executive Committee of Johnson & Johnson, the world’s premier health care company. Joaquin is responsible for the Company’s Pharmaceuticals and Consumer sectors, along with Supply Chain, Technology, Global Services and the Health & Wellness groups. He is a respected industry leader and past Chairman of the Pharmaceutical Research and Manufacturers of America.

As a member of the company for more than 30 years, Joaquin played an instrumental role in leading the turnaround of Johnson & Johnson’s Pharmaceuticals sector. Joaquin was named Company Group Chairman of the Americas in 2009. He then continued leading the global transformation upon his appointment to his role as Executive Vice President and Worldwide Chairman, Pharmaceuticals in 2011. During that time, the sector grew into what is today the third-largest innovative pharmaceutical company globally.

More recently in his role as Vice Chairman, Joaquin provides strategic direction for the sectors and functions he oversees. He helped guide the transformation of Johnson & Johnson’s Consumer Health sector, under which the business has renewed its focus on Self-Care and Skin Health brands that are rooted in science and endorsed by professionals. Additionally, Joaquin is championing the use of new technologies across Johnson & Johnson so the company can continue leading in a digital world, with a focus on the application of Data Science, Intelligent Automation and other digital technologies.

As a dual citizen of Spain and the United States with extensive experience living and working on-the-ground on multiple continents, Joaquin brings a unique international perspective to his work. His global experience has given him an appreciation for the value of diversity of thought and opinions, which he brings to bear externally as a UNICEF USA Board Member, Tsinghua University School of Pharmaceutical Sciences Advisory Board Member and Hess Corporation Board Member, and internally as the Executive Sponsor of the African Ancestry Leadership Council. His commitment to nurturing a culture of diversity and inclusion was recognized by the Healthcare Businesswomen’s Association (HBA) when he was named 2017 Honorable Mentor.

Joaquin has an undergraduate degree in economics and business, a Master of Business Administration degree from ESADE Business School in Barcelona and a Master of International Management degree from Thunderbird in Phoenix, Arizona. Follow Joaquin on Twitter at @joaquinduato.

Annie Lamont (HC/FT) is a Co-Founder and Managing Partner of Oak HC/FT where she focuses on growth equity and early-stage venture opportunities in Healthcare and FinTech.

Annie currently serves on the Boards of Brightline, CareBridge, Independent Living Systems, Oncology Analytics, OODA Health, Poynt, Precision Medicine Group, Quartet, Vesta Health, VillageMD and is a Board Observer at Notable. Annie is also actively involved with Devoted Health, Inscripta, and Komodo Health.

Prior investments include Aspire Health (acquired by Anthem), athenahealth (NASDAQ: ATHN) American Esoteric Laboratories (acquired by Sonic Healthcare Limited), Argus Information & Advisory Services (acquired by Verisk Analytics), Benefitfocus (NASDAQ: BNFT), CareMedic Systems (acquired by Ingenix), Castlight Health (NYSE: CSLT), CLARiENT (acquired by GE Healthcare), Health Dialog (acquired by British United Provident Association), iHealth Technologies (merged with Connolly to become Cotiviti), Odyssey Healthcare, Oak Tree (acquired by Oxford), NetSpend (acquired by TSYS), PayFlex Systems (acquired by Aetna), PharMEDium Healthcare (acquired by CD&R), Point Carbon (acquired by Thomson Reuters), Psychiatric Solutions (acquired by Universal Health Services), TxVia (acquired by Google), United BioSource (acquired by Medco Health Solutions) and Vesta Corporation.

Dr. Annette Lee graduated from Northeastern University and received her PhD from The Rockefeller University. She joined The Center for Genomics and Human Genetics as an Assistant Professor in 2001 and worked on the genetics of autoimmune diseases such as rheumatoid arthritis, lupus and inflammatory bowel disease. More recently as an associate investigator and director of the Laboratory of Translational Genetics, she has established her own area of research investigating the genetics of cancer—including chronic lymphocytic leukemia, breast and ovarian cancers.

Dr. Lee has directed the sample genotyping for several large autoimmune genome-wide association studies to identify risk genes for rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease (Crohn’s disease and ulcerative colitis), scleroderma, alopecia areata, IgA deficiency, myasthenia gravis and myositis. All of these studies have either resulted in publications in high profile journals or are in the process of being analyzed for manuscript submission. As a follow up to genome-wide studies, she has also supervised the selection and development of targeted genetic studies which range from a few variants to dense mapping of over 12,000 SNPs for several autoimmune diseases, Alzheimer’s, Parkinson’s, diabetic nephropathy and asthma. Several key genetic variants associated with human diseases have been identified as a direct result of these studies. More recently she has begun to study biomarkers of breast and ovarian cancers.

Dr. Lee has co-authored almost 100 peer-reviewed papers. Together with her collaborators throughout the Northwell Health enterprise, she has established a biobank of breast and ovarian tissue samples for research. Together with Dr Iuliana Shapira, Dr. Lee was honored at the Moms Who Kick 2012 Gala held at The Garden City Hotel for their research in breast cancer. Dr. Lee and Dr. Shapira were recently featured in the December 2012 televised series of Medical Updates.

Bernard Robinson MHA, EMT-P is a Regional Director of Operations for Northwell Health’s Center for Emergency Medical Services. He oversees the daily operation of one of the largest EMS agencies on the east coast with a staff of over 800 EMT’s and Paramedics that handles over 175,000 responses a year. An EMS professional for 28 years, Mr. Robinson serves on the health system’s Opioid Management Steering Committee (OSMC) and as the director of his departments Explorer Post in which the EMT’s and Paramedics mentor and train with high school students. Prior to joining Northwell, he worked as an EMT for FDNY EMS for 8 years where he worked on a Hazardous Materials (Haz-Tac) unit, among others.

In 2017, Mr. Robinson received the Nassau County EMS Leadership Award in recognition of his contributions to his department and the communities that they serve. In 2020 he received the inaugural Rev. Dr. Martin Luther King Jr. Spirit Award from Northwell Health in acknowledgement of his community service.

Eric Schmidt is an accomplished technologist, entrepreneur and philanthropist. He joined Google in 2001 and helped grow the company from a Silicon Valley startup to a global leader in technology alongside founders Sergey Brin and Larry Page. Eric served as Google’s Chief Executive Officer and Chairman from 2001-2011, as well as Executive Chairman and Technical Advisor. Under his leadership, Google dramatically scaled its infrastructure and diversified its product offerings while maintaining a strong culture of innovation. In 2017, he co-founded Schmidt Futures, a philanthropic initiative designed to help exceptional people do more for others by applying science and technology thoughtfully and working together across fields.